These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 5402998)

  • 1. [Pulmonary mycobacteriosis due to Mycobacterium battey with favorable development under medical treatment].
    Constans P; Parrot R; Aubriot G; Morin Y; Bariéty M
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):957-66. PubMed ID: 5402998
    [No Abstract]   [Full Text] [Related]  

  • 2. [Disposition to lung diseases caused by atypical mycobacteria; treatment results and late results].
    Krebs A
    Z Tuberk Erkr Thoraxorg; 1967; 127(1):133-40. PubMed ID: 5632190
    [No Abstract]   [Full Text] [Related]  

  • 3. Pulmonary Mycobacterium scrofulaceum infection in a child.
    Cooper AR; Martin RS
    Pediatrics; 1972 Jan; 49(1):118-24. PubMed ID: 5059291
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mycobacteriosis due to Mycobacterium intracellulare (Battey)].
    Lewit T; Herczeg F; Lewit R; Terracina S; Karman S
    Harefuah; 1973 Jun; 84(12):639-42. PubMed ID: 4732591
    [No Abstract]   [Full Text] [Related]  

  • 5. Isolation of atypical mycobacteria from cases simulating pulmonary tuberculosis.
    Saran R
    Indian J Chest Dis; 1973 Jan; 15(1):28-34. PubMed ID: 4633021
    [No Abstract]   [Full Text] [Related]  

  • 6. [Studies on discharge of atypical myocbacteria in ambulatory patients and treatment of pulmonary disease caused by atypical mycobacteria (so-called atypical mycobacteriosis)].
    Yamaguchi T; Toyohara M
    Kekkaku; 1967 Jul; 42(7):245-50. PubMed ID: 5583607
    [No Abstract]   [Full Text] [Related]  

  • 7. [Epidemiological and clinical studies in diseases with atypical mycobacteria].
    Schmiedel A
    Z Tuberk Erkr Thoraxorg; 1967; 127(1):141-3. PubMed ID: 5632191
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lung diseases due to atypical mycobacteria].
    Favez G
    Schweiz Med Wochenschr; 1975 Aug; 105(31):987-91. PubMed ID: 1153999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mycobacterium chelonei: friend or foe?
    McGrath EE; Qureshi N
    Eur Respir J; 2007 Aug; 30(2):397. PubMed ID: 17666565
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical mycobacteria in human disease. Review of literature with report of five strains isolated from cases of pulmonary tuberculosis.
    Rajvanshi VS; Tiagi GK
    Indian J Pathol Bacteriol; 1970 Jan; 13(1):21-9. PubMed ID: 5496978
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pulmonary mycobacteriosis caused by Mycobacterium avium. A recent case].
    Piéron R; Oustrieres G; Aigueperse J; Le Hegarat H; de Seguin M; Kourilsky R
    Sem Hop; 1970 Apr; 46(20):1369-72. PubMed ID: 4315721
    [No Abstract]   [Full Text] [Related]  

  • 12. [Two new cases of pulmonary mycobacteriosis due to Mycobacterium xenopi].
    Vayssairat M; Moulias R; Rameix P; Grosset J; Chomette G; Loeper J
    Ann Med Interne (Paris); 1973 Apr; 124(4):309-12. PubMed ID: 4720416
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary disease caused by Mycobacterium xenopi:two case reports.
    Tellis CJ; Beechler CR; Ohashi DK; Fuller SA
    Am Rev Respir Dis; 1977 Oct; 116(4):779-83. PubMed ID: 335935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Some current aspects of the bacteriological diagnosis of broncho-pulmonary infections due to conditioned pathogenic mycobacteria].
    Timoşca S; Petreanu V; Coman G; Georgescu M; Ianopol J
    Rev Med Chir Soc Med Nat Iasi; 1972; 76(1):95-102. PubMed ID: 4622750
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical feature of lung disease due to Mycobacterium intracellulare (author's transl)].
    Tsukamura M; Shimoide H; Segawa J; Kita N; Shirota N
    Kekkaku; 1974 May; 49(5):139-45. PubMed ID: 4408922
    [No Abstract]   [Full Text] [Related]  

  • 16. [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases].
    Eule H; Werner E; Winsel K; Iwainsky H
    Pharmazie; 1985 Apr; 40(4):276-7. PubMed ID: 4011667
    [No Abstract]   [Full Text] [Related]  

  • 17. [Non-tuberculous mycobacteria in Barcelona (II). Pulmonary mycobacteriosis].
    de March Ayuela P; Planells Romeo EI
    Rev Clin Esp; 1984 Dec 15-31; 175(5-6):187-94. PubMed ID: 6535201
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical significance of Mycobacterium fortuitum infections in pulmonary disease.
    Awe RJ; Gangadharam PR; Jenkins DE
    Am Rev Respir Dis; 1973 Nov; 108(5):1230-4. PubMed ID: 4746583
    [No Abstract]   [Full Text] [Related]  

  • 19. [What will be the future of human mycobacterioses?].
    Thibault P
    Presse Med (1893); 1971 Apr; 79(17):745-6. PubMed ID: 5553543
    [No Abstract]   [Full Text] [Related]  

  • 20. Pulmonary Mycobacterium sherrisii infection in a human immunodeficiency virus type 1-infected patient.
    Gämperli A; Bosshard PP; Sigrist T; Brändli O; Wildermuth S; Weber R; Mueller NJ
    J Clin Microbiol; 2005 Aug; 43(8):4283-5. PubMed ID: 16082002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.